Chemotherapy-induced peripheral neuropathy (CIPN) is a common peripheral nervous system injury in cancer treatment, specifically manifested as sensory abnormalities, neuropathic pain, and motor dysfunction, which significantly affects patients’ quality of life and chemotherapy progression. The core mechanism of CIPN involves the induction of mitochondrial dysfunction, leading to mitochondrial oxidative stress and metabolic dysfunction, followed by aberrant sodium/calcium channel function, resulting in neuronal apoptosis and nerve fiber degeneration. CIPN is classified as the “Xuebi” category in traditional Chinese medicine (TCM), results from drug toxicity, causing qi and blood deficiency and meridian obstruction. TCM interventions, based on “tonifying vital energy, activating meridians, and integrating internal-external therapy” aim to reduce nerve damage. This review summaries CIPN’s toxicological mechanisms and TCM-based pathogenesis, focusing on TCM therapeutic strategies. A treatment protocol, including “formula-based reinforcement, synergistic enhancement, external meridian penetration, and acupuncture regulation”, is proposed to improve chemotherapeutic outcomes and patient survival.
Key words
chemotherapy-induced peripheral neuropathy
/
oxaliplatin
/
paclitaxel
/
vincristine
/
traditional Chinese medicine therapy
CHEN Zhenyu, LIU Lu, YAO Shuning, WANG Yuefei.
Toxic mechanisms of chemotherapy-induced peripheral neuropathy and strategies for prevention and treatment with traditional Chinese medicine[J].
Chinese Traditional and Herbal Drugs,
2026
, 57
(6)
: 2356
-2367
.
DOI: 10.7501/j.issn.0253-2670.2026.06.028
基金
收起
现代中药新质生产力科技创新工程专项 (24ZXZKSY00010)
参考文献
收起
文献
收起
参考文献引证文献
排序方式：
Tilsed C M, Fisher S A, Nowak A K, et al. Cancer chemotherapy: Insights into cellular and tumor microenvironmental mechanisms of action[J]. Front Oncol, 2022, 12: 960317. Tubridy E A, Taunk N K, Ko E M. Treatment of node-positive endometrial cancer: Chemotherapy, radiation, immunotherapy, and targeted therapy[J]. Curr Treat Options Oncol, 2024, 25(3): 330-345. 王媛媛, 孙晖, 沈昆双, 等. 基于血清代谢组学探究复方阿胶浆改善乳腺癌联合化疗诱导疲乏小鼠抑郁情绪的作用机制[J]. 中草药, 2025, 56(19): 7055-7067. 孙放, 王如峰, 胡秀华. 中医药在乳腺癌化疗副作用中的临床应用概况[J]. 世界中西医结合杂志, 2015, 10(12): 1757-1760. 郭敏. 肿瘤化疗后胃肠道副作用的中医治疗研究进展[J]. 云南中医中药杂志, 2017, 38(12): 74-76. Sreeram K, Seaton R, Greenwald M K, et al. Chemotherapy-induced peripheral neuropathy in the Detroit research on cancer survivors (ROCS) cohort[J]. Cancer Causes Control, 2023, 34(5): 459-468. Desforges A D, Hebert C M, Spence A L, et al. Treatment and diagnosis of chemotherapy-induced peripheral neuropathy: An update[J]. Biomed Pharmacother, 2022, 147: 112671. Burgess J, Ferdousi M, Gosal D, et al. Chemotherapy-induced peripheral neuropathy: Epidemiology, pathomechanisms and treatment[J]. Oncol Ther, 2021, 9(2): 385-450. Beijers A J M, Mols F, Vreugdenhil G. A systematic review on chronic oxaliplatin-induced peripheral neuropathy and the relation with oxaliplatin administration[J]. Support Care Cancer, 2014, 22(7): 1999-2007. Marmiroli P, Riva B, Pozzi E, et al. Susceptibility of different mouse strains to oxaliplatin peripheral neurotoxicity: Phenotypic and genotypic insights[J]. PLoS One, 2017, 12(10): e0186250. Dolan M E, El Charif O, Wheeler H E, et al. Clinical and genome-wide analysis of cisplatin-induced peripheral neuropathy in survivors of adult-onset cancer[J]. Clin Cancer Res, 2017, 23(19): 5757-5768. Bae E H, Greenwald M K, Schwartz A G. Chemotherapy-induced peripheral neuropathy: Mechanisms and therapeutic avenues[J]. Neurotherapeutics, 2021, 18(4): 2384-2396. Staff N P, Cavaletti G, Islam B, et al. Platinum-induced peripheral neurotoxicity: From pathogenesis to treatment[J]. J Peripher Nerv Syst, 2019, 24(Suppl 2): S26-S39. Cavaletti G, Marmiroli P. Management of oxaliplatin-induced peripheral sensory neuropathy[J]. Cancers, 2020, 12(6): 1370. 中国抗癌协会肿瘤支持治疗专业委员会, 中国抗癌协会肿瘤临床化疗专业委员会, 巴一, 等. 化疗诱导的周围神经病变诊治中国专家共识(2022版)[J]. 中华肿瘤杂志, 2022, 44(9): 928-934. Maihöfner C, Diel I, Tesch H, et al. Chemotherapy-induced peripheral neuropathy (CIPN): Current therapies and topical treatment option with high-concentration capsaicin[J]. Support Care Cancer, 2021, 29(8): 4223-4238. Li G Z, Hu Y H, Li D Y, et al. Vincristine-induced peripheral neuropathy: A mini-review[J]. Neurotoxicology, 2020, 81: 161-171. Utsu Y, Takaishi K, Inagaki S, et al. Influence of dose reduction of vincristine in R-CHOP on outcomes of diffuse large B cell lymphoma[J]. Ann Hematol, 2016, 95(1): 41-47. Yamamoto S, Egashira N. Pathological mechanisms of bortezomib-induced peripheral neuropathy[J]. Int J Mol Sci, 2021, 22(2): 888. Arastu-Kapur S, Anderl J L, Kraus M, et al. Nonproteasomal targets of the proteasome inhibitors bortezomib and carfilzomib: A link to clinical adverse events[J]. Clin Cancer Res, 2011, 17(9): 2734-2743. Mileshkin L, Prince H M. The troublesome toxicity of peripheral neuropathy with thalidomide[J]. Leuk Lymphoma, 2006, 47(11): 2276-2279. Mileshkin L, Stark R, Day B, et al. Development of neuropathy in patients with myeloma treated with thalidomide: Patterns of occurrence and the role of electrophysiologic monitoring[J]. J Clin Oncol, 2006, 24(27): 4507-4514. Zhang S M. Chemotherapy-induced peripheral neuropathy and rehabilitation: A review[J]. Semin Oncol, 2021, 48(3): 193-207. Staff N P, Grisold A, Grisold W, et al. Chemotherapy-induced peripheral neuropathy: A current review[J]. Ann Neurol, 2017, 81(6): 772-781. Silva Baticam N, Roberge X, Laliberté I, et al. Ifosfamide-related optic nerve toxicity: Case description and review of the literature[J]. Pediatr Blood Cancer, 2025, 72(8): e31799. Liu J C, Wang D P, Callen E, et al. Mechanism of cytarabine-induced neurotoxicity[J]. Nature, 2025, 643(8074): 1400-1409. Seigers R, Timmermans J, van der Horn H J, et al. Methotrexate reduces hippocampal blood vessel density and activates microglia in rats but does not elevate central cytokine release[J]. Behav Brain Res, 2010, 207(2): 265-272. Mustafa S, Walker A, Bennett G, et al. 5-Fluorouracil chemotherapy affects spatial working memory and newborn neurons in the adult rat hippocampus[J]. Eur J Neurosci, 2008, 28(2): 323-330. Huang J, Zhao Y Z, Xu Y, et al. Comparative effectiveness and safety between oxaliplatin-based and cisplatin-based therapy in advanced gastric cancer: A Meta-analysis of randomized controlled trials[J]. Oncotarget, 2016, 7(23): 34824-34831. Webster R G, Brain K L, Wilson R H, et al. Oxaliplatin induces hyperexcitability at motor and autonomic neuromuscular junctions through effects on voltage-gated sodium channels[J]. Br J Pharmacol, 2005, 146(7): 1027-1039. Lehky T J, Leonard G D, Wilson R H, et al. Oxaliplatin-induced neurotoxicity: Acute hyperexcitability and chronic neuropathy[J]. Muscle Nerve, 2004, 29(3): 387-392. Anand U, Otto W R, Anand P. Sensitization of capsaicin and icilin responses in oxaliplatin treated adult rat DRG neurons[J]. Mol Pain, 2010, 6: 82. Bessac B F, Sivula M, von Hehn C A, et al. TRPA1 is a major oxidant sensor in murine airway sensory neurons[J]. J Clin Invest, 2008, 118(5): 1899-1910. Ballarini E, Malacrida A, Rodriguez-Menendez V, et al. Sodium-calcium exchanger 2: A pivotal role in oxaliplatin induced peripheral neurotoxicity and axonal damage?[J]. Int J Mol Sci, 2022, 23(17): 10063. Verma P, Eaton M, Kienle A, et al. Examining sodium and potassium channel conductances involved in hyperexcitability of chemotherapy-induced peripheral neuropathy: A mathematical and cell culture-based study[J]. Front Comput Neurosci, 2020, 14: 564980. Duan Z S, Su Z B, Wang H S, et al. Involvement of pro-inflammation signal pathway in inhibitory effects of rapamycin on oxaliplatin-induced neuropathic pain[J]. Mol Pain, 2018, 14: 1744806918769426. Podratz J L, Knight A M, Ta L E, et al. Cisplatin induced mitochondrial DNA damage in dorsal root ganglion neurons[J]. Neurobiol Dis, 2011, 41(3): 661-668. Canta A, Pozzi E, Carozzi V A. Mitochondrial dysfunction in chemotherapy-induced peripheral neuropathy (CIPN)[J]. Toxics, 2015, 3(2): 198-223. Avan A, Postma T J, Ceresa C, et al. Platinum-induced neurotoxicity and preventive strategies: Past, present, and future[J]. Oncologist, 2015, 20(4): 411-432. Wang J T, Medress Z A, Barres B A. Axon degeneration: Molecular mechanisms of a self-destruction pathway[J]. J Cell Biol, 2012, 196(1): 7-18. 周楠, 杨竞. 沃勒氏退行性病变的分子机制[J]. 生命科学, 2017, 29(3): 245-250. Wang J, Zhang X S, Tao R, et al. Upregulation of CX3CL1 mediated by NF-κB activation in dorsal root ganglion contributes to peripheral sensitization and chronic pain induced by oxaliplatin administration[J]. Mol Pain, 2017, 13: 1744806917726256. Di Cesare Mannelli L, Pacini A, Micheli L, et al. Glial role in oxaliplatin-induced neuropathic pain[J]. Exp Neurol, 2014, 261: 22-33. 刘立芝, 伍建宇, 吴志勇, 等. 奥沙利铂诱导性周围神经病的临床及电生理观察[J]. 中华医学杂志, 2016, 96(13): 1021-1025. Zang X W, Lee J B, Deshpande K, et al. Prevention of paclitaxel-induced neuropathy by formulation approach[J]. J Control Release, 2019, 303: 109-116. 胡嘉芮, 樊捷婷, 何晓华, 等. 紫杉醇致周围神经病变的研究进展[J]. 中国新药与临床杂志, 2023, 42(10): 616-621. Wozniak K M, Vornov J J, Wu Y, et al. Peripheral neuropathy induced by microtubule-targeted chemotherapies: Insights into acute injury and long-term recovery[J]. Cancer Res, 2018, 78(3): 817-829. Zheng H, Xiao W H, Bennett G J. Mitotoxicity and bortezomib-induced chronic painful peripheral neuropathy[J]. Exp Neurol, 2012, 238(2): 225-234. Gupta P, Makkar T K, Goel L, et al. Role of inflammation and oxidative stress in chemotherapy-induced neurotoxicity[J]. Immunol Res, 2022, 70(6): 725-741. Old E A, Nadkarni S, Grist J, et al. Monocytes expressing CX3CR1 orchestrate the development of vincristine-induced pain[J]. J Clin Invest, 2014, 124(5): 2023-2036. 巴茜远, 郝悦, 肖礼祖, 等. 化疗所致神经病理性疼痛机制的研究进展[J]. 中国疼痛医学杂志, 2021, 27(5): 367-371. Pozzi E, Terribile G, Cherchi L, et al. Ion channel and transporter involvement in chemotherapy-induced peripheral neurotoxicity[J]. Int J Mol Sci, 2024, 25(12): 6552. 张玲, 朱静. 紫杉醇所致周围神经病变的机制研究进展[J]. 中国疼痛医学杂志, 2022, 28(3): 204-209. Akin E J, Alsaloum M, Higerd G P, et al. Paclitaxel increases axonal localization and vesicular trafficking of Nav1.7[J]. Brain, 2021, 144(6): 1727-1737. Smith P A. K+ channels in primary afferents and their role in nerve injury-induced pain[J]. Front Cell Neurosci, 2020, 14: 566418. Carlson K, Ocean A J. Peripheral neuropathy with microtubule-targeting agents: Occurrence and management approach[J]. Clin Breast Cancer, 2011, 11(2): 73-81. Cormier A, Knossow M, Wang C G, et al. The binding of Vinca domain agents to tubulin: Structural and biochemical studies[J]. Methods Cell Biol, 2010, 95: 373-390. Lee B Y, Hur E M. A role of microtubules in oligodendrocyte differentiation[J]. Int J Mol Sci, 2020, 21(3): 1062. Xu T, Zhang X L, Ou-Yang H D, et al. Epigenetic upregulation of CXCL12 expression mediates antitubulin chemotherapeutics-induced neuropathic pain[J]. Pain, 2017, 158(4): 637-648. Zajączkowska R, Kocot-Kępska M, Leppert W, et al. Mechanisms of chemotherapy-induced peripheral neuropathy[J]. Int J Mol Sci, 2019, 20(6): 1451. Keifer J A, Guttridge D C, Ashburner B P, et al. Inhibition of NF-κB activity by thalidomide through suppression of IκB kinase activity[J]. J Biol Chem, 2001, 276(25): 22382-22387. 孟晶, 朱静. 中药防治化疗所致周围神经病变的研究进展[J]. 南京中医药大学学报, 2018, 34(6): 634-638. 王倩. 中药泡洗手足治疗化疗所致外周神经毒性的疗效观察[J]. 中国中医药科技, 2021, 28(6): 1000-1002. 温钧涵, 刘歆, 谭松. 中医外治法治疗紫杉类药物所致周围神经毒性研究进展[J]. 河南中医, 2023, 43(12): 1938-1944. 孙佳, 胡佳倩, 顾祥, 等. 中药熏洗结合针刺治疗白蛋白结合型紫杉醇所致外周神经损伤的临床研究[J]. 现代医学与健康研究: 电子版, 2023, 7(12): 25-27. 韩芸, 节阳华, 张洪亮. 中医外治奥沙利铂引起周围神经病变的进展[J]. 新疆中医药, 2016, 34(1): 84-86. 张世恩, 刘晓明. 基于“虚气留滞”探讨线粒体自噬在糖尿病周围神经病变中的作用[J]. 现代中医临床, 2025, 32(5): 107-112. 王媛, 王艳, 马铭, 等. 线粒体功能障碍在化疗所致周围神经病变中的作用机制研究进展[J]. 药物不良反应杂志, 2022, 24(12): 658-663. 杨兆硕, 莫美, 董强, 等. 中医药临床优势病种探讨: 化疗相关性周围神经病变[J]. 中国实验方剂学杂志, 2025, 31(19): 288-298. 邱林景, 王晓磊, 吴长江, 等. 基于气络学说及线粒体功能障碍论治糖尿病周围神经病变[J]. 中医学报, 2025, 40(2): 255-260. 倪雪, 孙涛. 化疗诱导周围神经毒性的中西医治疗进展[J]. 辽宁医学杂志, 2022, 36(3): 92-96. 陆新, 曲琳卓, 王勇, 等. 化疗诱导的周围神经病变的发病机制及治疗进展[J]. 中国药理学通报, 2025, 41(1): 18-22. Gauchan P, Andoh T, Ikeda K, et al. Mechanical allodynia induced by paclitaxel, oxaliplatin and vincristine: Different effectiveness of gabapentin and different expression of voltage-dependent calcium channel alpha(2)delta-1 subunit[J]. Biol Pharm Bull, 2009, 32(4): 732-734. Lu Y T, Zhang P, Zhang Q Y, et al. Duloxetine attenuates paclitaxel-induced peripheral nerve injury by inhibiting p53-related pathways[J]. J Pharmacol Exp Ther, 2020, 373(3): 453-462. Privitera R, Anand P. Capsaicin 8% patch Qutenza and other current treatments for neuropathic pain in chemotherapy-induced peripheral neuropathy (CIPN)[J]. Curr Opin Support Palliat Care, 2021, 15(2): 125-131. 张梅梅, 龚志成, 陈艳琰. 奥沙利铂致神经毒性的中西医认知及中药防治研究进展[J]. 中国中药杂志, 2023, 48(17): 4610-4619. 于源, 陈丽娟, 孙金芳. 中西医治疗化疗药物诱导周围神经病变临床研究进展[J]. 世界中医药, 2024, 19(9): 1348-1354. 魏国利, 顾展丞, 李灵常, 等. 黄芪桂枝五物汤减少铂蓄积预防奥沙利铂慢性外周神经毒性机制研究[J]. 世界科学技术—中医药现代化, 2019, 21(7): 1467-1473. 李冲, 王钰, 张文静, 等. 黄芪桂枝五物汤治疗糖尿病周围神经病变的研究进展[J]. 中草药, 2024, 55(12): 4235-4247. 钱叶斌, 陶有略, 黄翠芬, 等. 补阳还五汤促进周围神经损伤后神经元存活的实验研究[J]. 实用手外科杂志, 2002, 16(3): 152-154. 文汉英, 朱创洲.“补阳还五汤加味”防治奥沙利铂所致外周神经毒性反应30例临床观察[J]. 江苏中医药, 2010, 42(3): 42-43. 胡莹, 霍介格, 曹鹏, 等. 当归四逆汤防治奥沙利铂致慢性周围神经病变[J]. 中国实验方剂学杂志, 2013, 19(20): 255-258. Masanori N, Mitsuo S, Nobuhiro K, et al. The Kampo medicine, Goshajinkigan, prevents neuropathy in patients treated by FOLFOX regimen[J]. Int J Clin Oncol, 2011, 16(4): 322-327. 王静. 参附注射液对奥沙利铂神经毒性的预防作用[J]. 现代中西医结合杂志, 2012, 21(24): 2659-2660. 计磊, 陈世壮. 参麦注射液降低紫杉醇周围神经毒性反应的临床观察[J]. 实用医药杂志, 2013, 30(3): 232. 魏晓晨, 朱立勤, 王春革, 等. 参麦注射液预防恶性肿瘤化疗所致周围神经毒性效果的系统评价[J]. 山东医药, 2016, 56(28): 45-47. 骆曼. 黄芪注射液防治结直肠癌患者奥沙利铂相关性神经毒性的临床研究[D]. 武汉: 湖北中医药大学, 2012. 钟敏钰, 罗秀丽. 川芎嗪对紫杉醇致神经病理性疼痛大鼠的疗效及其对坐骨神经中神经生长因子表达的影响[J]. 临床神经病学杂志, 2016, 29(3): 198-202. 高云. 川芎嗪对初级感觉神经元P2X_3受体介导的痛觉传递的影响和机制研究[D]. 南昌: 南昌大学, 2007. 贺菊芳, 张彩云, 陈瑞睿, 等. 穴位艾灸治疗配合艾盐包热熨治疗奥沙利铂化疗所致外周神经毒性疗效观察[J]. 中西医结合护理: 中英文, 2018, 4(5): 74-76. 李倩, 袁春意, 秦洁. 温经通络方熏洗联合甲钴胺治疗化疗相关周围神经病变30例[J]. 湖南中医杂志, 2024, 40(11): 1-4. Vickers A J, Vertosick E A, Lewith G, et al. Acupuncture for chronic pain: Update of an individual patient data Meta-analysis[J]. J Pain, 2018, 19(5): 455-474. 卢超, 冯绪康, 沈琼颖, 等. 不同频率电针治疗紫杉类化疗药物所致周围神经病变: 随机对照试验[J]. 中国针灸, 2024, 44(10): 1139-1145. Hanai A, Ishiguro H, Sozu T, et al. Effects of cryotherapy on objective and subjective symptoms of paclitaxel-induced neuropathy: Prospective self-controlled trial[J]. J Natl Cancer Inst, 2018, 110(2): 141-148. 钟文娟, 何苗, 曾小莉, 等. 冷冻疗法联合当归四逆汤对白蛋白结合型紫杉醇化疗诱导的周围神经病变的疗效观察[J]. 赣南医科大学学报, 2025, 45(4): 329-333. Kleckner I R, Kamen C, Gewandter J S, et al. Effects of exercise during chemotherapy on chemotherapy-induced peripheral neuropathy: A multicenter, randomized controlled trial[J]. Support Care Cancer, 2018, 26(4): 1019-1028.
PDF下载
全屏
29
11
关闭全屏
北京市海淀区学院南路86号
010-62199257（仅加盟咨询）
qkjq@cast.org.cn
